BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38849761)

  • 21. Synergistic Effect of Berberine Hydrochloride and Fluconazole Against
    Yong J; Zu R; Huang X; Ge Y; Li Y
    Front Microbiol; 2020; 11():1498. PubMed ID: 32714312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
    Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S
    Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against
    Raut JS; Bansode BS; Jadhav AK; Karuppayil SM
    J Microbiol Biotechnol; 2017 Apr; 27(4):685-693. PubMed ID: 28138121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effect of fluconazole and doxycycline against Candida albicans biofilms resulting from calcium fluctuation and downregulation of fluconazole-inducible efflux pump gene overexpression.
    Gao Y; Li H; Liu S; Zhang X; Sun S
    J Med Microbiol; 2014 Jul; 63(Pt 7):956-961. PubMed ID: 24809386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of fluconazole resistance-associated genes in biofilm from 23 clinical isolates of Candida albicans.
    Shi C; Liu J; Li W; Zhao Y; Meng L; Xiang M
    Braz J Microbiol; 2019 Jan; 50(1):157-163. PubMed ID: 30617866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verapamil inhibits efflux pumps in
    Vega-Chacón Y; de Albuquerque MC; Pavarina AC; Goldman GH; Mima EGO
    Virulence; 2021 Dec; 12(1):231-243. PubMed ID: 33410730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
    Nailis H; Vandenbosch D; Deforce D; Nelis HJ; Coenye T
    Res Microbiol; 2010 May; 161(4):284-92. PubMed ID: 20170727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal activity of Rubus chingii extract combined with fluconazole against fluconazole-resistant Candida albicans.
    Han B; Chen J; Yu YQ; Cao YB; Jiang YY
    Microbiol Immunol; 2016 Feb; 60(2):82-92. PubMed ID: 26891940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fungicidal action of geraniol against Candida albicans is potentiated by abrogated CaCdr1p drug efflux and fluconazole synergism.
    Singh S; Fatima Z; Ahmad K; Hameed S
    PLoS One; 2018; 13(8):e0203079. PubMed ID: 30157240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
    Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps.
    Zhang H; Gao A; Li F; Zhang G; Ho HI; Liao W
    Yakugaku Zasshi; 2009 May; 129(5):623-30. PubMed ID: 19420894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid composition and cell surface hydrophobicity of Candida albicans influence the efficacy of fluconazole-gentamicin treatment.
    Suchodolski J; Muraszko J; Korba A; Bernat P; Krasowska A
    Yeast; 2020 Jan; 37(1):117-129. PubMed ID: 31826306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
    Mukherjee PK; Chandra J; Kuhn DM; Ghannoum MA
    Infect Immun; 2003 Aug; 71(8):4333-40. PubMed ID: 12874310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.
    Sun LM; Liao K; Liang S; Yu PH; Wang DY
    J Appl Microbiol; 2015 Apr; 118(4):826-38. PubMed ID: 25641229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms.
    Li Y; Yang J; Li X; Su S; Chen X; Sun S; Li Y
    Int J Antimicrob Agents; 2020 Aug; 56(2):106030. PubMed ID: 32454072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.
    Haque F; Alfatah M; Ganesan K; Bhattacharyya MS
    Sci Rep; 2016 Mar; 6():23575. PubMed ID: 27030404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
    Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
    FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal activity of dexamethasone against fluconazole-resistant
    Silva LJ; Silva CR; Sá LG; Barroso FD; Cândido TM; Queiroz HA; Almeida Moreira LE; Baccallini OV; Cavalcanti BC; Silva J; Marinho ES; Moraes MO; Neto JB; Júnior HV
    Future Microbiol; 2022 May; 17():607-620. PubMed ID: 35411812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.